GBGB9612063.9A
GB9612063D0
(en)
|
1996-06-10 |
1996-06-10 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
NZ332670A
NZ332670A
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases comprising 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5H)-furanone
|
US09/180,647
US6063811A
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once day treatment of cyclooxygenase-2 mediated diseases
|
YU51698A
YU51698A
(en)
|
1996-05-17 |
1997-05-13 |
Pharmaceutical composition for the treatment of cyclooxygenase-2 mediated diseases, said composition comprising a cyclooxygenase-2 inhibiting compound characterized by high potency, a long half-life and a high degree of specificity for inhibiting cyclooxygenase-2
|
CA002254061A
CA2254061C
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
CZ19983738A
CZ291463B6
(en)
|
1996-05-17 |
1997-05-13 |
Pharmaceutical composition
|
BR9709097A
BR9709097A
(en)
|
1996-05-17 |
1997-05-13 |
Pharmaceutical composition for the treatment of diseases mediated by cyclooxygenase process to treat an inflammatory disease susceptible to treatment with an anti-inflammatory agent in the steroid use and oral form of unit dose
|
AU30049/97A
AU3004997A
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
EE9800393A
EE03746B1
(en)
|
1996-05-17 |
1997-05-13 |
A pharmaceutical composition for the treatment of cyclooxygenase-2 mediated diseases, the use of 3-phenyl-4- (4- (methylsulfonyl) phenyl) -2- (5H) -furanone, and a unit oral dosage form
|
HU9902889A
HUP9902889A3
(en)
|
1996-05-17 |
1997-05-13 |
The use of 3-phenyl-4-(4-methylsulphonyl)-phenyl-2-(5h)-furanone for producing anti inflammatory medicaments and such medicaments
|
KR10-1998-0709239A
KR100373622B1
(en)
|
1996-05-17 |
1997-05-13 |
One-time therapeutic composition for diseases mediated with cyclooxygenase-2
|
CNB971963150A
CN1140267C
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
PCT/US1997/008041
WO1997044028A1
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
EA199801017A
EA001596B1
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for the treatment of cyclooxygenase-2 mediated diseases and method of treating an inflammatory disease
|
TR1998/02345T
TR199802345T2
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for once-daily administration in cyclooxygenase-2-mediated diseases.
|
UA98126685A
UA51706C2
(en)
|
1996-05-17 |
1997-05-13 |
Method for treating inflammatory diseases by administering 3-phenyl-4-(4-methylsulfonyl)phenyl)-2-(5h)-furanone
|
IL12689997A
IL126899A
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
JP9542486A
JPH11512754A
(en)
|
1996-05-17 |
1997-05-13 |
Composition for once-daily treatment of cyclooxygenase-2-mediated disease
|
SK1567-98A
SK284330B6
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
EP97924688A
EP0910368A1
(en)
|
1996-05-17 |
1997-05-13 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
DZ970087A
DZ2200A1
(en)
|
1996-05-17 |
1997-05-14 |
Compositions for once daily treatment of diseases mediated by 2-cyclooxygenase.
|
ARP970102021A
AR012014A1
(en)
|
1996-05-17 |
1997-05-14 |
COMPOSITIONS FOR TREATMENT OF A DAY OF DISEASES MEDIATED BY CYCLOOXYGENASE-2
|
PE1997000379A
PE66998A1
(en)
|
1996-05-17 |
1997-05-15 |
DAILY DOSE TREATMENT COMPOSITIONS FOR DISEASES PRODUCED BY CYCLOOXYGENASE-2
|
MYPI97002138A
MY116201A
(en)
|
1996-05-17 |
1997-05-16 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
HR9612063.9A
HRP970262A2
(en)
|
1996-05-17 |
1997-05-16 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases
|
IDP971640A
ID16921A
(en)
|
1996-05-17 |
1997-05-16 |
COMPOSITION FOR A DAY TREATMENT AGAINST DISEASES RELATED BY CYCLOXIGENASE-2
|
CO97026568A
CO5050370A1
(en)
|
1996-05-17 |
1997-05-16 |
COMPOSITIONS FOR A TREATMENT OF DAILY SINGLE DOSE OF DISEASES MEDIATED BY CYCLOOXYGENASE -2
|
IS4891A
IS4891A
(en)
|
1996-05-17 |
1998-11-10 |
Compositions for once-daily treatment of cyclooxygenase-2-dependent diseases
|
NO985342A
NO985342L
(en)
|
1996-05-17 |
1998-11-16 |
Preparation for treatment Once per. day of cyclooxygenase-2-mediated diseases
|
BG103000A
BG103000A
(en)
|
1996-05-17 |
1998-12-08 |
Compositions for single daily dosage in the treatment of cyclooxygenase-2-dependent diseases
|
PL97329940A
PL188649B1
(en)
|
1996-05-17 |
1999-01-11 |
Compositions for once-a-day administration for use in treating diseases involving mediator effect of cyclooxygenase-2
|
HK00100645A
HK1021623A1
(en)
|
1996-05-17 |
2000-02-02 |
Compositions for a once a day treatment of cyclooxygenase-2 mediated diseases.
|